Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In SituSteven A. Narod, Ping Sun|JAMA Oncology|2015Cited by 618
Effect of Short-Term Hormone Replacement Therapy on Breast Cancer Risk Reduction After Bilateral Prophylactic Oophorectomy in <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers: The PROSE Study GroupTimothy R. Rebbeck, Barbara Weber, Laura van ‘t Veer et al.|Journal of Clinical Oncology|2005Cited by 406
Germline <i>BRCA</i> Mutations in a Large Clinic-Based Cohort of Patients With Pancreatic AdenocarcinomaSpring Holter, Steven Gallinger, Ayelet Borgida et al.|Journal of Clinical Oncology|2015Cited by 396
Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriersAmy Finch, Terence J. Colgan, Patricia Shaw et al.|Gynecologic Oncology|2005Cited by 377
Occult Carcinoma in Prophylactic Oophorectomy SpecimensTerence J. Colgan, Barry P. Rosen, Joan Murphy et al.|The American Journal of Surgical Pathology|2001Cited by 335